A Cognitive Training Tool Based on Life-logging in Mild Cognitive Impairment (ReMemory-MCI)
NCT ID: NCT02592187
Last Updated: 2019-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2015-06-30
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: The main goal of the present study is to develop a Cognitive Training program (CT) for MCI based on life-logging captured by a Wearable Camera (WeC) recording specific autobiographical episodes for stimulating posteriorly episodic memory. The challenge is to create an application to manage this large collection of images, which can be easily retrieved as events by users in a therapeutic context as a multimodal cognitive stimulation. The investigators will conduct a quasi-experimental design with non-equivalent control group, evaluating the effectiveness of the life-logging re-experiencing program immediately and 3-month follow-up period.
Methodology: The design is a pretest, posttest and follow-up design, where 30 adults with MCI were sequentially allocated to one of two conditions: intervention or control group. All subjects wore a lifelogging WeC during two weeks, and subsequently they were generated several videos with the most relevant information of each event. Subjects in the Intervention Group will attend 1-hour individual training sessions 2 times per week for 14 8 weeks. Main outcomes measures will be cognitive, functional, emotional and quality of life measures, as well as biochemical measures (BDNF).
Expected results: The investigators expect the outcomes to provide preliminary evidence that autobiographical experimentation CT programs can positively impact cognitive functioning and may represent an effective strategy to improve memory and functionality in those who begun to experience cognitive decline.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial to Evaluate the Effectiveness of Memory Training Workshops in People From 65 to 80 Years
NCT02431182
Non-randomized Clinical Trial on Cognitive Stimulation With Virtual Reality in Patients With Mild Cognitive Impairment
NCT06977815
Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training
NCT01628653
Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease
NCT02176629
Self-defining Memories in Patients With a TBI
NCT02680210
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental intervention
ReMemory-MCI training
ReMemory-MCI training
Control intervention
Control intervention
Control intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ReMemory-MCI training
Control intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meet definition criteria for MCI (Petersen, 2004)
* Be receiving CT at least three month in Day Hospital during three months or more; c) having memory complaint, usually verified by an informant
* Having memory complaint, usually verified by an informant
* Memory performance below the mean score for the corresponding age and education group
* Having normal general cognitive functioning as determined by a Mini-Mental State Examination (MMSE) score \> o = 24
* Having a reliable caregiver who can supervise the patient's daily activities
* Having Global clinical dementia rating scale score of 0.5
* Granted written informed consent accepting to participate in the study
Exclusion Criteria
* Intellectual deficiency (Premorbid Intellectual Quotient (IQ) -Vocabulary- less 85)
* Relevant hearing, vision, motor or language deficits
* Less than 4 years of education e) acquisition of Catalonian or Spanish languages after 15 years old
65 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Barcelona
OTHER
Associació Vallès Amics de la Neurologia
OTHER
Fundació La Marató de TV3
OTHER
Consorci Sanitari de Terrassa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maite Garolera
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maite Garolera, PhD
Role: PRINCIPAL_INVESTIGATOR
Consorci Sanitari de Terrassa
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Fundacio la MaratóTV3 20141510
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.